Stoke Therapeutics, Inc. (STOK)
29.72
-0.33
(-1.10%)
USD |
NASDAQ |
Sep 09, 10:51
Stoke Therapeutics Total Assets (Quarterly) : 393.97M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 393.97M |
| March 31, 2026 | 443.28M |
| December 31, 2025 | 418.43M |
| September 30, 2025 | 360.26M |
| June 30, 2025 | 384.51M |
| March 31, 2025 | 406.89M |
| December 31, 2024 | 271.56M |
| September 30, 2024 | 293.32M |
| June 30, 2024 | 307.76M |
| March 31, 2024 | 205.18M |
| December 31, 2023 | 228.34M |
| September 30, 2023 | 239.89M |
| June 30, 2023 | 256.92M |
| March 31, 2023 | 281.80M |
| December 31, 2022 | 256.07M |
| September 30, 2022 | 277.63M |
| Date | Value |
|---|---|
| June 30, 2022 | 301.43M |
| March 31, 2022 | 315.94M |
| December 31, 2021 | 238.86M |
| September 30, 2021 | 253.77M |
| June 30, 2021 | 264.45M |
| March 31, 2021 | 278.91M |
| December 31, 2020 | 297.92M |
| September 30, 2020 | 199.94M |
| June 30, 2020 | 210.21M |
| March 31, 2020 | 220.84M |
| December 31, 2019 | 228.75M |
| September 30, 2019 | 238.83M |
| June 30, 2019 | 246.37M |
| March 31, 2019 | 102.93M |
| December 31, 2018 | 107.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 32.09B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.42M |
| Shareholders Equity (Quarterly) | 345.55M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 7.692 |
| Net Debt Paydown Yield | 0.02% |